Clinical Trial: Clinical efficacy study protocol for the application of high-dose rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) in translateral anterior lumbar interbody fusion (OLIF). (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy study protocol for the application of high-dose rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) in translateral anterior lumbar interbody fusion (OLIF).'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129844

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: West China Hospital, Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=321142

Published by HT Digital Content Services with permission from Health Daily Digest....